Navigation Links
Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
Date:11/27/2007

MENLO PARK, Calif., Nov. 27 /PRNewswire/ -- Corium International, Inc., a privately-held transdermal drug delivery company, today announced the appointment of Phyllis Gardner, M.D. and Daniel G. Welch to the Board of Directors. Dr. Gardner, an adjunct partner at Essex Woodlands Health Ventures, is a Professor of Medicine at Stanford University and widely published in the fields of cell biology and pharmacology. In addition to her academic work, Dr. Gardner has been active in the biotechnology and pharmaceutical industries. In 1996, she took a leave of absence from Stanford and joined ALZA Corporation as a Principal Scientist, Vice President of Research, and Head of the ALZA Technology Institute. Dr. Gardner is the co-founder of Genomics Collaborative, Inc. (now a division of Bioserve), SKOLAR MD (acquired by Wolters Klure) and APEX DX, LLC. She currently serves on the boards of Ventaira Pharmaceuticals, UMD, Inc., and Revance, Inc., and she is on the Scientific Advisory Board of Aradigm Corp. Dr. Gardner received her M.D. from Harvard Medical School, and received postgraduate training at Massachusetts General Hospital, Stanford School of Medicine, Columbia University and University College London.

Daniel G. Welch has served as Chief Executive Officer and President of InterMune since September 2003. Prior to InterMune, Mr. Welch was Chairman and CEO of Triangle Pharmaceuticals, a biopharmaceutical company, which was acquired by Gilead. From 2000 to 2002, he was President of Biopharmaceuticals at Elan Corporation where he was responsible for U.S. commercial operations, the international subsidiaries, the R&D function and the diagnostics businesses. Mr. Welch served in several senior management roles at Sanofi-Aventis during the years 1987 to 2000, including Vice President of Worldwide Marketing and COO of the U.S. business. Prior to joining Sanofi-Aventis, Mr. Welch was with American Critical Care, a division of American Hospital Supply. Mr. Welch is a m
'/>"/>

SOURCE Corium International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
2. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a ... its catalogue: ,, Carbondioxide Incubators - ... http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators are the ... cancer, research, and other applications for providing ...
(Date:12/2/2009)... TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... in a dose confirmation and dosimetry trial of Cotara® ... form of brain cancer. Cotara is a targeted ... a potential new treatment for GBM. Cotara specifically ...
(Date:12/2/2009)... TechConnect World, an event bringing together the ... cleantech, nanotech, biotech and MEMS, announced the December ... ,, Now in its 14th year, TechConnect World, ... Institute (NSTI), and the Clean Technology and Sustainable ...
(Date:12/2/2009)... China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" ... a leading pharmaceutical company,specializing in the development, manufacturing, ... China, today announced that 105 of,its drugs have ... which was issued by China,s Ministry of Human ...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... finalist teams vie for cash prizes awarded for nation,s best ... ... 22 The National Inventors Hall of,Fame Foundation today announced ... of finalists includes,undergraduate and graduate students from across the country ...
... Genzyme Corporation,(Nasdaq: GENZ ) has announced findings ... satisfaction following,viscosupplementation treatments with Synvisc and Hyalgan in ... demonstrated that Synvisc,provided longer knee pain relief and ... led by orthopaedic surgeon Raghu Raman and a ...
... MYL ),today confirmed that the company and its subsidiary, ... with Fluvastatin Capsules,USP, 20 mg (base) and 40 mg ... believes it is the first company to file a ... IV,certification for the product. The company filed an ANDA ...
Other Biology Technology:Collegiate Inventors Competition(R) Recognizes Top Student Inventors 2Collegiate Inventors Competition(R) Recognizes Top Student Inventors 3Collegiate Inventors Competition(R) Recognizes Top Student Inventors 4Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 2Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 3Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R) 2
(Date:12/4/2009)... new mathematical model of heart cells, University of Iowa ... calmodulin kinase II (CaM kinase), disrupts the electrical activity ... also involved Columbia University, was published online Dec. 3 ... , "Recently, researchers have developed great interest in calmodulin ...
(Date:12/3/2009)... Harald zur Hausen and his co-workers discovered that specific ... soon found out how these pathogens cause cells to ... are viral proteins E6 and E7. Both proteins switch ... , Professor Dr. Frank Rsl and his co-workers ...
(Date:12/3/2009)... windows or solar panels that repels grime and dirt? ... New Tel Aviv University research, just published in ... at the nano-scale level that could make these futuristic ... Operating in the range of 100 nanometers (roughly one-billionth ...
Breaking Biology News(10 mins):U-Iowa study helps advance heart-related research 2Papillomavirus silences innate immune response 2A window that washes itself? 2Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 14291 1Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 14291 2Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 14291 3Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 14291 4Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 1Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 1Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 3
... sequence and assembly of the six billion base pairs from ... individualized genomics , Researchers at the J. Craig Venter Institute ... in Toronto and the University of California San Diego (UCSD), ... that covers both sets of chromosomes that were inherited from ...
... populations of two species oscillate together (for example, predators and ... ecologically. A famous example is the Canadian lynx and snowshoe ... Company. But is the opposite also true" If the preys ... they are not tightly linked in the food web" Among ...
... A ground-based, experimental model used to simulate astronaut ... to study the effects of stress on immune organs. ... this model implicated the protein osteopontin (OPN) in bone ... research was made possible by the creation at Rutgers ...
Other Biology News:First individual genome sequence published 2First individual genome sequence published 3First individual genome sequence published 4Hidden interactions between predators and prey: evolution causes cryptic dynamics in ecology 2Mice stressed in simulated weightlessness show organ atrophy 2Mice stressed in simulated weightlessness show organ atrophy 3
... selects single cells, or clusters, with rapid, ... all, a single cell can be targeted, ... collected into the pipette, and automatically transferred ... plate. Quixells unique aspiration and expulsion system ...
... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... Microarray contains all known virus microRNAs ...
... forefront of Agilent analytical solutions is the ... networking (LAN) allows you to share business ... informed decision making. Just as its 6890 ... flexibility and performance needed for research and ...
The novel and unique HCTplus delivers unmatched information-rich data-dependent LC/MSn data for todays challenge in proteomics and metabonomics work....
Biology Products: